Ajanta Pharma releases Q2 FY26 earnings call transcript
Ajanta Pharma Limited announced on November 6, 2025, the release of the written transcript for its earnings call conducted on November 3, 2025. This disclosure is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
The earnings call, held at 3:00 p.m. on November 3, 2025, discussed the company's financial performance for the second quarter (July-September) of the fiscal year 2025-26. The full transcript has been uploaded to the company's official website and is accessible via a direct link provided in the announcement.
The communication, signed by Gaurang Shah, senior vp – legal & company secretary, serves to inform stakeholders and provides a permanent record of the proceedings.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Ajanta Pharma publishes news
Free account required • Unsubscribe anytime